pharmaceutical drugs
671 projects
HEIndividual fellowship2025–2027United Kingdom
DeDAMPL · Exploring a Dehydrating/condensation enzyme Domain for a Diversified Antimicrobial Peptide Library
2 partners · 2 countries
HEDoctoral network2025–2028Germany
ENDAMR · Exploring Novel Drivers of Anti-Microbial Resistance
16 partners · 9 countries
HEStaff exchange2025–2028Greece
i-GREENPHARM · AI and machine learning assisted development of greener formulations and pharmaceutical processes based on amorphous solid dispersions
10 partners · 6 countries
HEIndividual fellowship2025–2027Spain
SPADYN-SM · Spatiotemporal dynamics of secondary metabolism in the ocean microbiome
2 partners · 2 countries
HEIndividual fellowship2025–2027France
TRANSPEPTID · Developing new antibiotic peptides targeting ESKAPE bacterial trans- translation
2 partners
HEIndividual fellowship2025–2027Spain
REDAVIP · Restoring DNASEs antiviral potential
HEDoctoral network2024–2028Italy
SECRET · Exploring the therapeutic potential of perinatal cell SECRETomes
11 partners · 6 countries
HEDoctoral network2024–2028Sweden
MeCHaNiSM · Mechanical Characterisation of Nucleic Acids using Single Molecule Methods
12 partners · 6 countries
HEDoctoral network2024–2029Ireland
PROTEMIC · Integrated Spectroscopy for Protein Analysis Using Metasurfaces and Interband/Quantum Cascade Devices
10 partners · 5 countries
HEDoctoral network2024–2028Austria
CAARE · Characterization and Recovery of Bionanoparticles for Vaccine Delivery and Gene Therapy
17 partners · 6 countries
HEIndividual fellowship2024–2026Norway
BioAlgae · Bioactive polyphenolic compounds from brown macroalgae: A mechanistic study on pig gut health promoting effects (BioAlgae)
2 partners · 2 countries
HEIndividual fellowship2024–2026Spain
HALO · EXPLORING NOVEL HALO-PHOTOAUTOTROPHS FOR A CIRCULAR BIOECONOMY VIA TRANSFORMATION OF SYNGAS INTO MEDICAL AND PHARMACEUTICAL COMPOUNDS
3 partners · 3 countries
HEIndividual fellowship2024–2026Denmark
DNANOMETAL · Design of metal-stabilized DNA and RNA nanoconstructs potentially applicable in medicine
HEIndividual fellowship2024–2026Ireland
HEAD-P · Harnessing Evidence on Adverse drug withdrawal events following Deprescribing through the Pharmacovigilance system (HEAD-P)
HEIndividual fellowship2024–2026Belgium
RespiriCO · Immunological mechanisms of respiratory co-infections
HEIndividual fellowship2024–2026Greece
LeVec · Molecular characterization of insecticide resistance and transmission competence in sand flies, major vectors of leismaniasis
2 partners · 2 countries
HEIndividual fellowship2024–2026Spain
ROSCURE-O2 · Development and evaluation of Radical Oxygen Species (ROS)-responsive drug delivery systems to prevent and cure inflammatory and hypoxic diseases.
HEIndividual fellowship2024–2026Italy
METACT · METabolic interplay petween peroxisome-endoplasmic reticulum contACT sites and mitochondria-endoplasmic reticulum contact sites during metabolic dysfunction-associated fatty liver disease
HEIndividual fellowship2024–2026Netherlands
SprayDelivery · Pulmonary drug delivery using low shear nebulization sprays
2 partners
HEIndividual fellowship2024–2027Czechia
LeishBlock · Exploring an antileishmanial drug toolbox for blocking pathogen transmission in the sand fly vector.
3 partners · 3 countries
HEIndividual fellowship2024–2026Netherlands
MemProDx · The dynamic structure of protein domains within the cytoplasmic membrane of Escherichia coli
HEIndividual fellowship2024–2026Spain
BPYMAC · Bipyridines as Mediating Artificial Cofactors to replace NAD(P)H
HEIndividual fellowship2024–2026Germany
REXPO · Residual executive power (REXPO). EU institutional balance and regulatory patterns after the Covid19 crisis
HEIndividual fellowship2024–2026Sweden